论文部分内容阅读
Objective To evaluate the efficacy and safety of ivabradine for the treatment of Chinese patients with chronic heart failure based on the Chinese subgroup data of the systolic heart failure treatment with the Ifinhibitor ivabradine trial(SHIFT).Methods A total of 6 558 stable outpatients who presented symptoms of heart failure,with a
Objective To evaluate the efficacy and safety of ivabradine for the treatment of Chinese patients with chronic heart failure based on the Chinese subgroup data of the systolic heart failure treatment with the Ifinhibitor ivabradine trial (SHIFT). Methods A total of 6 558 stable outpatients who presented symptoms of heart failure, with a